Eli Lilly raises forecasts as diabetes drug Mounjaro powers upbeat results - Reuters
- Eli Lilly raises forecasts as diabetes drug Mounjaro powers upbeat results Reuters
- Eli Lilly raises full-year guidance as Mounjaro, other drugs drive second-quarter profit up 85% CNBC
- Soaring sales of diabetes drug Mounjaro, widely used for weight loss, sends Eli Lilly to new heights AOL
- Eli Lilly Stock Price Heads for Record High, Thanks to Weight-Loss Drug Mounjaro The Wall Street Journal
- View Full Coverage on Google News